No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use*
-
Aged
-
Aged, 80 and over
-
Angiotensin Receptor Antagonists*
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Diastole / drug effects
-
Drug Evaluation
-
Evidence-Based Medicine / methods
-
Female
-
Heart / drug effects
-
Heart Failure / complications
-
Heart Failure / diagnosis
-
Heart Failure / drug therapy*
-
Heart Failure / metabolism*
-
Heart Failure / physiopathology
-
Humans
-
Male
-
Middle Aged
-
Mineralocorticoid Receptor Antagonists*
-
Neurotransmitter Agents / metabolism*
-
Prognosis
-
Systole / drug effects
-
Ventricular Dysfunction / drug therapy
-
Ventricular Dysfunction / etiology
-
Ventricular Dysfunction / physiopathology
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Mineralocorticoid Receptor Antagonists
-
Neurotransmitter Agents